The prognostic value of using the duration of acute kidney injury in cardiac surgery: An example using two antifibrinolytics

Journal of Extra-Corporeal Technology

Volumn 43, Issue 4, 2011, Pages 227-231

  Brown, Jeremiah R ^a   Kramer, Robert S ^b   Coca, Steven G ^c,d   Parikh, Chirag R ^c,d  

^a DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^b MAINE MEDICAL CENTER   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute kidney injury; Amicar; Aprotinin; Cardiac outcomes; Cardiopulmonary bypass

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; APROTININ; CREATININE;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIALYSIS; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE MARKER; DISEASE SEVERITY; DRUG MEGADOSE; FEMALE; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PROGNOSIS; SURGICAL MORTALITY; SURVIVAL TIME; BLOOD; CARDIOPULMONARY BYPASS; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ACUTE KIDNEY INJURY; AGED; ANTIFIBRINOLYTIC AGENTS; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CREATININE; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84860548143     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Brown JR, Kramer RS, Coca SG, et al. Duration of acute kidney injury impacts long-term survival following cardiac surgery. Ann Thorac Surg. 2010;90:1142-8.
2. Brown JR, Birkmeyer NJ, O'Connor GT. Aprotinin in cardiac surgery. N Engl J Med. 2006;354:1953-7; author reply 1953-7.
3. Brown JR, Birkmeyer NJ, O'Connor GT. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation. 2007;115:2801-13.
4. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: Report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.
5. Wentworth DN, Neaton JD, Rasmussen WL. An evaluation of the Social-Security-Administration Master Beneficiary Record File and the National-Death-Index in the ascertainment of vital status. Am J Public Health. 1983;73:1270-4.
6. Stata [computer program]. Version Release 9.0. College Station, TX: Stata Statistical Software; 2005.
7. Wagener G, Gubitosa G, Wang S, et al. Increased incidence of acute kidney injury with aprotinin use during cardiac surgery detected with urinary NGAL. Am J Nephrol. 2008;28:576-82.
8. Fauli A, Gomar C, Campistol JM, et al. Kidney-specific proteins in patients receiving aprotinin at high- and low-dose regimens during coronary artery bypass graft with cardiopulmonary bypass. Eur J Anaesthesiol. 2005;22:666-71.
9. Nguyen MT, Dent CL, Ross GF, et al. Urinary aprotinin as a predictor of acute kidney injury after cardiac surgery in children receiving aprotinin therapy. Pediatr Nephrol. 2008;23:1317-26.